Cellular senescence molecules expression in type 2 diabetes mellitus: CDKN2A, CDKN2B, and lncRNA ANRIL

被引：1
|
作者：
Anaraki, Soheila [1 ]
Kheirandish, Masoumeh [2 ]
Mousavi, Pegah [3 ]
Tamandegani, Atefe Ebrahimi [1 ]
Mohammadi, Samane [1 ]
Shekari, Mohammad [1 ]
机构：
[1] Hormozgan Univ Med Sci, Fac Med, Dept Med Genet, Bandar Abbas 7919915519, Iran
[2] Hormozgan Univ Med Sci, Endocrinol & Metab Res Ctr, Bandar Abbas, Iran
[3] Hormozgan Univ Med Sci, Hormozgan Hlth Inst, Mol Med Res Ctr, Bandar Abbas, Iran
来源：
GENE | 2024年 / 911卷
关键词：
Biomarker; Long noncoding RNA; Cyclin-dependent kinase inhibitor 2A /2B; CDKN2B-AS1; Real-time PCR; Peripheral blood mononuclear cells; INFLAMMATION; DISEASE; CELLS;
D O I：
10.1016/j.gene.2024.148319
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Aims: Cellular senescence in type 2 diabetes mellitus (T2DM) has received widespread attention. However, the cellular senescence molecules involved in T2DM are unclear. Furthermore, there are no consistent biomarkers for cellular senescence in T2DM. Therefore, this study aimed to identify cellular senescence molecules in T2DM and investigate their expression in peripheral blood mononuclear cells of individuals with T2DM. Methods: Patients with T2DM (n = 40) and healthy controls (n = 40) were enrolled. We used different databases to identify cellular senescence molecules in T2DM and confirmed the obtained genes and lncRNA using real-time PCR. Results: Bioinformatics analysis indicated that CDKN2A and CDKN2B genes, and long noncoding RNA ANRIL are the most effective cellular senescence molecules in T2DM. Furthermore, CDKN2A and ANRIL expression decreased in individuals with T2DM. Conclusions: Cellular senescence may have a protective effect against T2DM. In addition, the cellular senescence molecules CDKN2A and ANRIL may be potential biomarkers of cellular senescence in T2DM.
引用
收藏
页数：7
相关论文
共 50 条
  • [41] Aberrant DNA methylation of CDKN2B gene in the Type 1 diabetes mellitus and analysis of epigenetic markers
    Vijayaragavan, P.
    Purushothaman, Sumitha
    Arokiyaraj, Selvaraj
    Rathi, M. A.
    Gopalakrishnan, V. K.
    Gatasheh, Mansour K.
    Sivanesan, Ravikumar
    JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2023, 35 (08)
  • [42] CDKN2A/B polymorphism is associated with susceptibility to type 2 diabetes, but not with the gene expression in the adipose tissues in the Japanese
    Omori, S.
    Tanaka, Y.
    Maegawa, H.
    Kashiwagi, A.
    Kawamori, R.
    Kaku, K.
    Nakamura, Y.
    Maeda, S.
    DIABETOLOGIA, 2008, 51 : S139 - S139
  • [43] B-cell receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter transformation
    Chakraborty, Supriya
    Martines, Claudio
    Porro, Fabiola
    Fortunati, Ilaria
    Bonato, Alice
    Dimishkovska, Marija
    Piazza, Silvano
    Yadav, Brijesh S.
    Innocenti, Idanna
    Fazio, Rosa
    Vaisitti, Tiziana
    Deaglio, Silvia
    Zamo, Alberto
    Dimovski, Aleksandar J.
    Laurenti, Luca
    Efremov, Dimitar G.
    BLOOD, 2021, 138 (12) : 1053 - 1066
  • [44] Pan-cancer genomic variation characteristics of CDKN2A/CDKN2B/CCND1 in Chinese patients.
    Yu, Songfeng
    Li, Qiyong
    Dai, Lei
    Zhao, Peng
    Zhuang, Li
    Qian, Yigang
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [45] The Yin and Yang-Like Clinical Implications of the CDKN2A/ARF/CDKN2B Gene Cluster in Acute Lymphoblastic Leukemia
    Gonzalez-Gil, Celia
    Ribera, Jordi
    Ribera, Josep Maria
    Genesca, Eulalia
    GENES, 2021, 12 (01) : 1 - 27
  • [46] Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours
    Schmidt, EE
    Ichimura, K
    Messerle, KR
    Goike, HM
    Collins, VP
    BRITISH JOURNAL OF CANCER, 1997, 75 (01) : 2 - 8
  • [47] CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A
    Tu, Q.
    Hao, J.
    Zhou, X.
    Yan, L.
    Dai, H.
    Sun, B.
    Yang, D.
    An, S.
    Lv, L.
    Jiao, B.
    Chen, C.
    Lai, R.
    Shi, P.
    Zhao, X.
    ONCOGENE, 2018, 37 (01) : 128 - 138
  • [48] Germline heterozygous deletion containing CDKN2A/CDKN2B as genetic substrate for rare familial neural and skin tumor syndrome
    Hannes, Laurens
    Brems, Hilde
    Clement, Paul
    De Vleeschouwer, Steven
    Garmyn, Marjan
    Sciot, Raf
    Van Calenbergh, Frank
    Legius, Eric
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 583 - 583
  • [49] CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A
    Q Tu
    J Hao
    X Zhou
    L Yan
    H Dai
    B Sun
    D Yang
    S An
    L Lv
    B Jiao
    C Chen
    R Lai
    P Shi
    X Zhao
    Oncogene, 2018, 37 : 128 - 138
  • [50] TOX and CDKN2A/B Gene Polymorphisms Are Associated with Type 2 Diabetes in Han Chinese
    Fengjiang Wei
    Chunyou Cai
    Shuzhi Feng
    Jia Lv
    Shen Li
    Baocheng Chang
    Hong Zhang
    Wentao Shi
    Hongling Han
    Chao Ling
    Ping Yu
    Yongjun Chen
    Ning Sun
    Jianli Tian
    Hongxiao Jiao
    Fuhua Yang
    Mingshan Li
    Yuhua Wang
    Lei Zou
    Long Su
    Jingbo Li
    Ran Li
    Huina Qiu
    Jingmin Shi
    Shiying Liu
    Mingqin Chang
    Jingna Lin
    Liming Chen
    Wei-Dong Li
    Scientific Reports, 5
12345